Universities and colleges
Ligand-Independent Activation of Arylhydrocarbon Receptor in Breast Cancer Cells
Recent research from Sacramento, California, has shed light on the ligand-independent activation of the arylhydrocarbon receptor (AHR) in certain types of breast tumors. The study, led by Y. Fujisawa and colleagues at the University of California, discovered that estrogen receptor-negative, AHR overexpressing MCF10AT1 human breast cancer cells (designated P20E) showed